scispace - formally typeset
Journal ArticleDOI

Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals

Reads0
Chats0
TLDR
This review focuses on the use of fluoroquinolones within veterinary medicine, providing an overview of the structure-activity relationship of the various members of the group, the clinical uses offluoroquolones in veterinary Medicine, their pharmacokinetics and potential interspecies differences, and a summary of toxicities associated with this class of compounds.
Abstract
The fluoroquinolones are a class of compounds that comprise a large and expanding group of synthetic antimicrobial agents. Structurally, all fluoroquinolones contain a fluorine molecule at the 6-position of the basic quinolone nucleus. Despite the basic similarity in the core structure of these molecules, their physicochemical properties, pharmacokinetic characteristics and microbial activities can vary markedly across compounds. The first of the fluoroquinolones approved for use in animals, enrofloxacin, was approved in the late 1980s. Since then, five other fluoroquinolones have been marketed for use in animals in the United States, with others currently under investigation. This review focuses on the use of fluoroquinolones within veterinary medicine, providing an overview of the structure-activity relationship of the various members of the group, the clinical uses of fluoroquinolones in veterinary medicine, their pharmacokinetics and potential interspecies differences, an overview of the current understanding of the pharmacokinetic/pharmacodynamic relationships associated with fluoroquinolones, a summary of toxicities that have been associated with this class of compounds, their use in both in human and veterinary species, mechanisms associated with the development of microbial resistance to the fluoroquinolones, and a discussion of fluoroquinolone dose optimization. Although the review contains a large body of basic research information, it is intended that the contents of this review have relevance to both the research scientist and the veterinary medical practitioner.

read more

Citations
More filters
Journal ArticleDOI

Fluoroquinolone antibiotics: an emerging class of environmental micropollutants

TL;DR: This review shows that fluoroquinolone antibiotics have a wide spread use and that their behavior during wastewater treatment is complex with an incomplete removal, and that these biorecalcitrant compounds are present in different environmental matrices at potentially hazardous concentrations for the aquatic environment.
Journal ArticleDOI

Occurrence and fate of quinolone and fluoroquinolone antibiotics in a municipal sewage treatment plant.

TL;DR: The major factor in the removal of FQs in the STP was sorption to sludge, which was not governed by hydrophobic interactions, and a significant positive correlation was found between removal efficiencies and K(d) of F Qs.
Journal ArticleDOI

Drugs in development for toxoplasmosis: advances, challenges, and current status.

TL;DR: The facets of toxoplasmosis that are pertinent to drug design and the advances, challenges, and current status of preclinical drug research for toxoplasmsosis are discussed.
Journal ArticleDOI

Pharmacokinetics of veterinary drugs in laying hens and residues in eggs: a review of the literature

TL;DR: The available data suggest that, when administered to laying hens, a wide variety of drugs leave detectable residues in eggs laid days to weeks after the cessation of treatment.
Journal ArticleDOI

Preparation, characterization and pharmacokinetics of enrofloxacin-loaded solid lipid nanoparticles: Influences of fatty acids

TL;DR: The results suggest that the enrofloxacin-fatty acid SLN are promising formulations for sustained release while fatty acids had significant influences on the characteristics and performances of the SLN.
References
More filters
Journal ArticleDOI

Bacterial biofilms : A common cause of persistent infections

TL;DR: Improvements in understanding of the genetic and molecular basis of bacterial community behavior point to therapeutic targets that may provide a means for the control of biofilm infections.
Journal ArticleDOI

Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men

TL;DR: The potential value of using pharmacokinetic/pharmacodynamic parameters as guides for establishing optimal dosing regimens for new and old drugs and for new emerging pathogens and resistant organisms should make the continuing search for the therapeutic rationale of antibacterial dosing of mice and men worthwhile.
Journal ArticleDOI

Molecular basis of bacterial outer membrane permeability.

TL;DR: It is becoming increasingly clear that the outer membrane is very important in the physiology of gram-negative bacteria in making them resistant to host defense factors such as lysozyme, P-lysin, and various leukocyte proteins.
Journal ArticleDOI

Quinolone resistance from a transferable plasmid

TL;DR: Although resistance was low in wild-type strains, higher levels of quinolone resistance arose readily by mutation, suggesting that a multiresistance plasmid can speed the development and spread of resistance to these valuable antimicrobial agents.
Journal ArticleDOI

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.

TL;DR: The rationale and tools needed for targeting the dosage of intravenous ciprofloxacin to individual patients' pharmacokinetics and their bacterial pathogens' susceptibilities are provided and shown to be more precise than current guidelines.
Related Papers (5)